Join the Asuragen Team for the European Society of Human Genetics Conference 2024
Come and discover how we aim to unlock diagnostic challenges in rare diseases.
Come and say hello at stand #516
Equitable Genetic Coverage
We are committed to advancing equitable healthcare by offering comprehensive genetic coverage. Our extensive range of genetic tests and services ensures patients receive accurate diagnoses, personalized treatment plans, and improved outcomes.
Innovative Approaches to Cancer Monitoring
We are proud to share our innovative approaches to cancer monitoring and management. Through state-of-the-art technologies and groundbreaking research, we strive to revolutionize cancer care by early detection, targeted therapies, and effective management strategies.
Coming Soon:
AmplideX® Nanopore Carrier Plus Kit*†
A Long-Range PCR and Long-Read Sequencing Solution for Carrier Screening Research
Join Our Corporate Satellite Meeting
Meeting Room New York 1
Sunday 2 June // 12:00–13:00 CEST
Unravelling Complexity Through Innovation: Combining AmplideX PCR Chemistries and Nanopore Sequencing for Robust Variant Characterisation in 11 Hard-to-Decipher Genes
Striving for Simplicity: Prototype Assay Performance with a Panel of 11 Challenging Genes Using Nanopore Sequencing and AmplideX Chemistry
Dr. John Milligan
R&D Director, Asuragen, a Bio-Techne brand
Evaluation of a Streamlined Nanopore Sequencing Workflow for Rare Variant Characterisation in a Laboratory Setting
Prof. Anne-Sophie Lebre
Professor at the University of Reims
Champagne-Ardenne, Consultant Reims University Hospital
Get a Teaser on What Our Customers Expect of the AmplideX Nanopore Carrier Plus Kit
Featured Posters
View new data reinforcing our commitment to more equitable comprehensive genetic coverage in healthcare.
Prof. Anne-Sophie Lebre
Beta Evaluation of the AmplideX® PCR Enrichment Technology with ONT Long-Read DNA Sequencing of a Panel of Eleven Challenging Genes
Dr. John Milligan
Combining AmplideX PCR Chemistries, Nanopore Sequencing, and Automated Analysis Software to Genotype Complex, Genetic Variants in 11 Challenging Targets Associated with Hereditary Diseases
*For research purpose only. Not for use in diagnostic procedures.
†This product is under development; performance characteristics and final product features to be determined.